World Study News Today

ROCKLAND, Mass.--(BUSINESS WIRE)--Jan 22, 2024--

Merck a leading science and technology company today announced new realworld data that continue to reinforce the JAVELIN Bladder regimen of firstline platinumbased chemotherapy followed by BAVENCIO avelumab maintenance as a standard of care for eligible patients with locally advanced or metastatic urothelial carcinoma UC who do not progress on firstline chemotherapy.

“When you’re smiling, the whole world smiles with you” so went the old song popularised by Frank Sinatra, Nat King Cole, and Louis Armstrong. 

Drs. Dorff and McKay discuss real-world data from DEAR trial comparing darolutamide, enzalutamide and apalutamide, providing clinical pearls on their experiences to optimize outcomes.

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse...

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large B-cell lymphoma Additional presentations...

U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for adagrasib in combination with cetuximab in patients with KRASG12C-mutated advanced colorectal cancer whose... | December 21, 2022

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented data detailing the baseline characteristics of patients with Parkinsons disease...

Older IBD patients with comorbidities are less likely to be hospitalized due to an infection if they are treated with vedolizumab or ustekinumab than with an anti-TNF agent, suggests a US study.

Data available from Public Health Scotland shows that cases of ovarian cancer in 2021 are much higher than the 2017-2019 average, and deaths of new-born babies have reached the upper warning threshold indicating factors beyond random variation...